Amicus Therapeutics Shareholders Are Reminded of the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Amicus Therapeutics Shareholders Are Reminded of the December 7, 2015 Deadline to Seek Lead Plaintiff Status in Pending Securities Fraud Class Action

BOSTON, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Block & Leviton LLP, the law firm that filed the first securities class action against Amicus Therapeutics, Inc. (“Amicus” or the “Company”) (NASDAQ: FOLD ) is reminding investors that the deadline for seeking lead plaintiff status in the pending securities class action against Amicus is December 7, 2015. Investors who purchased Amicus securities between the expanded class period of March 19, 2015 and October 1, 2015 are eligible for inclusion in the action, and to be considered as lead plaintiffs.    

The pending action charges that Amicus and certain of its officers misrepresented when Amicus would be able to file its New Drug Application with the Food and Drug Administration (“FDA”) for its oral small molecule pharmacological chaperone migalastat for the treatment of Fabry disease.  Defendants publicly stated that, based on information provided by the FDA, the NDA was on track for filing in the fourth quarter of 2015.  Yet on October 2, 2015, Amicus revealed that it would no longer be in a position to submit its NDA in the fourth quarter of 2015.  Amicus’ stock price plunged on this news, falling by 54% to $6.39 per share.

Amicus investors are reminded that if they wish to become a lead plaintiff, they must file a motion by December 7, 2015.

If you are interested in becoming a lead plaintiff, have questions about your legal rights, or if you have information relevant to this investigation, please contact attorneys Jake Walker or Jeffrey Block of Block & Leviton LLP at (617) 398-5600 or at Jake@blockesq.com or Jeff@blockesq.com .  You may also retain counsel of your own choosing.  Confidentiality for any whistleblowers or other persons with information relevant to the investigation is assured.

Block & Leviton represents investors for violations of securities laws as well as whistleblowing employees who provide information about their employers’ violations of law throughout the country.  The firm’s lawyers have collectively been prosecuting securities cases for over 70 years, have recovered billions of dollars for investors and represent some of the nation’s largest institutional investors.

This notice may constitute attorney advertising.

Contact: BLOCK & LEVITON LLP Jake Walker Jake@blockesq.com Jeffrey Block Jeff@blockesq.com (617) 398-5600

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 2

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 6

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Ama La Vida's New Coaching: More Than a Financial Plan

Updated Category News Views 0

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 2

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 2

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 3

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 1

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 1

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 67

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Samsung Partners with AI Innovators for Galaxy S26 Launch

Updated Category News Views 234

Samsung’s Ambitious AI Integration for Galaxy S26 Samsung Electronics SSNLF is actively pursuing partnerships with OpenAI and Perplexity AI as it strives to incorporate a wider array of artificial intelligence capabilities into its next-generation Galaxy devices. The company's intent is to diversify its AI services, significantly reducing its previous dependency on...

Continue Reading
Orion Corporation's Recent Share Transactions by Eija Ronkainen

Updated Category News Views 151

Overview of Managers' Transactions at Orion Corporation Orion Corporation is committed to transparency and accountability in its operations. Recently, a disclosure was made concerning share transactions involving Eija Ronkainen, a notable member of the company's Board. This transaction is governed by the Market Abuse Regulation (EU) No 596/2014. Details of the Disclosure...

Continue Reading
Essity Reports Strong Performance Amid Economic Challenges

Updated Category News Views 215

Continuous Growth and Resilience in Tough Times Essity's recent interim report for the second quarter of 2025 showcases the company's ability to navigate through economic headwinds while maintaining a focus on growth and innovation. Even with a challenging economic backdrop, Essity demonstrated a stronger financial performance, indicating a commitment to both its...

Continue Reading
Lantheus Holdings Faces Class Action Lawsuit from Shareholders

Updated Category News Views 132

Lantheus Holdings and the Class Action Lawsuit Lantheus Holdings, Inc. (NASDAQ: LNTH) is currently embroiled in a securities fraud class action lawsuit that has garnered attention from investors. This development comes after a shareholder filed a suit on behalf of those who acquired shares of the company between specific dates in 2025. Details of the Lawsuit The lawsuit...

Continue Reading
Ménage à Trois Introduces New Low-Calorie White Wine

Updated Category News Views 154

Ménage à Trois Introduces Light Sauvignon Blanc Fresh and flavorful, the Light Sauvignon Blanc from Ménage à Trois is set to delight consumers while catering to the growing demand for low-alcohol wines. With only 90 calories and 8% alcohol by volume, this new addition reflects the brand's commitment to providing products that align with modern lifestyles. Expanding...

Continue Reading